Analyst Sees Almost 83% Upside for Penny Stock Vaxart, Specializing in Oral Vaccines
According to an analyst, the penny stock Vaxart is in a unique position with potential for nearly 83% upside. The company focuses on developing oral vaccines, which sets it apart in the market. This news comes as a positive sign for investors looking to capitalize on the growing demand for vaccine options.